Lauren M. Sabella - 03 Sep 2021 Form 4 Insider Report for ACORDA THERAPEUTICS INC

Role
Chief Commercial Officer
Signature
/s/ Lauren Sabella
Issuer symbol
N/A
Transactions as of
03 Sep 2021
Net transactions value
-$6,618
Form type
4
Filing time
08 Sep 2021, 07:21:30 UTC
Next filing
07 Sep 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACOR Common Stock Tax liability $6,618 -1,511 -11% $4.38 12,221 03 Sep 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the number of shares of the issuer's Common Stock that were withheld to cover tax liability in connection with vesting and settlement of restricted stock units reported on a prior Form 4.